Relation between macular morphology and treatment frequency during twelve months with ranibizumab for diabetic macular edema.
Yuki MoriTomoaki MurakamiKiyoshi SuzumaKenji IshiharaShin YoshitakeMasahiro FujimotoYoko DodoTatsuya YoshitakeYuko MiwaAkitaka TsujikawaPublished in: PloS one (2017)
The retinal thickness in the inferior subfield predicts the treatment frequency during the first year in eyes with DME treated with PRN IVR injections.